Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

SPP1⁺ macrophage-derived WNT5A contributes to MMP11⁺ myCAF-mediated matrix remodeling and immunotherapy resistance in lung adenocarcinoma

Lung adenocarcinoma (LUAD) is the leading subtype of non-small cell lung cancer. However, the stromal-immune circuits that coordinate matrix remodeling and immunotherapy resistance in LUAD remain incompletely understood. This study aimed to characterize the stromal-immune interactions associated with LUAD progression a...

Meng-Lei Wang, Peng-Cheng Zhang, Xue-Feng Li et al. · 0 citations
Open access Aug 2026

Clostridium Butyricum and butyrate enhance PD-1 inhibitor therapy in non-small cell lung cancer by regulating the HDAC1/ID2/IL-12R pathway

Highlights • NaB and C. butyricum enhance PD-1 inhibitor activity in NSCLC.• NaB and C. butyricum offer an alternative therapeutic mechanism via HDAC1 inhibition.• NaB cooperates with the PD-1 inhibitors depending on CD8+ T cells in NSCLC.

Zhuo Chen, Meng-Lei Wang, Zhuo-Wen Zhang et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.